Telmisartan Clinical Trials

• ONTARGET: ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Tria Parallel Trial. TRANSCEND Telmisartan Randomized AssessmeNt Study in aCE iNtolerant Subjects with Cardiovascular Disease Trial.
  ClinicalTrials.gov Identifier: NCT00153101 - Active, not recruiting
  Cardiovascular Diseases
  
• An Eight Week Randomized, Double-Blind, Double-Dummy Study Comparing a Fixed Dose Combination of Telmisartan 80mg Plus Hydrochlothiazide 12.5mg to Telmisartan 80mg in Patients Who Fail to Respond Adequately to Treatment With Telmisartan 80mg
  ClinicalTrials.gov Identifier: NCT00146341 - Completed
  Hypertension
  
• Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial
  ClinicalTrials.gov Identifier: NCT00147264 - Active, not recruiting
  Metabolic Syndrome X
  
• A Randomised, Double-Blind Study Comparing a Fixed Dose Combination of Telmisartan 40 Mg Plus Hydrochlorothiazide 12.5 Mg to Telmisartan 40 Mg (Micardis®) in Patients Who Fail to Respond Adequately to Treatment with Telmisartan (Micardis®) 40 Mg
  ClinicalTrials.gov Identifier: NCT00144222 - Completed
  Hypertension
  
• Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension
  ClinicalTrials.gov Identifier: NCT00558428 - Recruiting
  Hypertension
  
• Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
  ClinicalTrials.gov Identifier: NCT00553267 - Recruiting
  Hypertension
  
• A Randomised, Double-Blind, Placebo-Controlled, 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension.
  ClinicalTrials.gov Identifier: NCT00153049 - Completed
  Hypertension
  
• A Randomised, Double-Blind, Placebo-Controlled, Multicenter Trial to Investigate the Preventive Effect of BIBR277 (Telmisartan (Micardis®, Gliosartan®, Kinzal®, Kinzalmono®, Predxal®, Pritor®, Samertan®, Telmisartan®
  ClinicalTrials.gov Identifier: NCT00153088 - Completed
  Diabetic Nephropathies
  
• The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00471003 - Active, not recruiting
  Hypertension
  
• Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00316095 - Active, not recruiting
  Hypertension; Dyslipidemias
  
• Compliance With Antihypertensive Telmisartan Therapy (COAST)
  ClinicalTrials.gov Identifier: NCT00470886 - Recruiting
  Hypertension
  
• Filtered Trial for Telmisartan 40mg Non-Responder
  ClinicalTrials.gov Identifier: NCT00550953 - Recruiting
  Hypertension
  
• Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
  ClinicalTrials.gov Identifier: NCT00509470 - Recruiting
  Essential Hypertension
  
• Observational Non-Interventional Study (Anwendungsbeobachtung) With Telmisartan in High-Risk Hypertensives
  ClinicalTrials.gov Identifier: NCT00539487 - Recruiting
  Hypertension; Obesity
  
• PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
  ClinicalTrials.gov Identifier: NCT00153062 - Active, not recruiting
  Cerebrovascular Accident
  
• Telmisartan vs. valsartan missed dose
  ClinicalTrials.gov Identifier: NCT00034840 - Completed
  Hypertension
  
• Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) – The ROSITEL Study
  ClinicalTrials.gov Identifier: NCT00486187 - Recruiting
  Type 2 Diabetes Mellitus
  
• Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients
  ClinicalTrials.gov Identifier: NCT00288717 - Recruiting
  Hypertension
  
• Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
  ClinicalTrials.gov Identifier: NCT00281580 - Recruiting
  Hypertension
  
• A Prospective, Randomised, Double-Blind, Double-Dummy, Forced-Titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nep
  ClinicalTrials.gov Identifier: NCT00168857 - Active, not recruiting
  Hypertension; Diabetic Nephropathies
  
• Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00560430 - Not yet recruiting
  Hypertension; Metabolic Syndrome; Hypertriglyceridemia
  
• Open-Label Trial of the Efficacy and Safety of Combination of Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg Tablets in Patients With Hypertension.
  ClinicalTrials.gov Identifier: NCT00267943 - Completed
  Hypertension
  
• Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00452192 - Recruiting
  Metabolic Syndrome
  
• Trial of Telmisartan 80mg/HCTZ 12.5mg and Telmisartan 40mg/HCTZ 12.5mg in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00326768 - Completed
  Hypertension
  
• A Prospective, Randomised, Double-Blind, Double-Dummy, Forced-Titration, Multicentre, Parallel Group, One Year Treatment Trial to Investigate the Efficacy of Telmisartan 80 Mg Versus Valsartan 160 Mg in Hypertensive Type 2 Diabetic Patients with Overt Nep
  ClinicalTrials.gov Identifier: NCT00153023 - Completed
  Diabetic Nephropathies; Hypertension
  
• A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00538486 - Not yet recruiting
  Hypertension; Obesity
  
• Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels
  ClinicalTrials.gov Identifier: NCT00559286 - Not yet recruiting
  Arterial Hypertension; Diabetes Mellitus Type 2 IRC or NIR
  
• A Randomized, Double-Blind, Parallel-Group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison with Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients with Mild to Modera
  ClinicalTrials.gov Identifier: NCT00133185 - Completed
  Hypertension
  
• Treatment of Insulin Resistance in Hypertensive, Obese Adolescents
  ClinicalTrials.gov Identifier: NCT00185705 - Recruiting
  Hypertension; Insulin Resistance; Dyslipidemia
  
• Telmisartan and Losartan in Hypertensive IGT
  ClinicalTrials.gov Identifier: NCT00407862 - Completed
  Hypertension; Impaired Glucose Tolerance
  
• A Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Phase IV Study Comparing Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg [Micardis HCT] Versus Valsartan 160 Mg + Hydrochlorothiazide 25 Mg [Diovan HCT] Taken Orally for Eight Weeks in Patien
  ClinicalTrials.gov Identifier: NCT00168779 - Completed
  Hypertension
  
• PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
  ClinicalTrials.gov Identifier: NCT00274599 - Completed
  Hypertension
  
• DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril
  ClinicalTrials.gov Identifier: NCT00274118 - Completed
  Hypertension; Diabetes Mellitus, Type 2
  
• Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension
  ClinicalTrials.gov Identifier: NCT00281593 - Completed
  Hypertension
  
• A Randomized, Double-Blind, Placebo Controlled Comparison of Telmisartan HCT and Valsartan HCT in HTN Stage I/II Patient
  ClinicalTrials.gov Identifier: NCT00240448 - Completed
  Hypertension
  
• Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes
  ClinicalTrials.gov Identifier: NCT00208221 - Terminated
  Hypertension; Type 2 Diabetes; Microalbuminuria
  
• Telmisartan in Haemodialysis Patients With Chronic Heart Failure
  ClinicalTrials.gov Identifier: NCT00490958 - Completed
  Heart Failure, Congestive
  
• PROBE Parallel 6-wk Treatment Comparing Telmisartan/HCT (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using ABPM
  ClinicalTrials.gov Identifier: NCT00274638 - Completed
  Hypertension
  
• Outcome Study ONTARGET
  ClinicalTrials.gov Identifier: NCT00034931 - No longer recruiting
  Coronary Disease; Angina Pectoris; Cerebrovascular Accident; Myocardial Infarction
  
• A Prospective, Randomized, Double-Blind, Double-Dummy, Forced Titration, Parallel Group Comparison, Multicenter Trial to Compare the Effects of Either Telmisartan (40-80 mg p.o. Once Daily) or Ramipril (5-10 mg p.o. Once Daily) on Renal Endothelial Dysfun
  ClinicalTrials.gov Identifier: NCT00240422 - Completed
  Diabetes Mellitus, Type 2; Hypertension
  
• A Comparison of Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg With Amlodipine 10 mg + Hydrochlorothiazide 12.5 mg in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. A Prospective, Randomised, Open-Label, Blinded
  ClinicalTrials.gov Identifier: NCT00240474 - Completed
  Hypertension
  
• The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-Diabetic, Normotensive Subjects.
  ClinicalTrials.gov Identifier: NCT00146289 - Completed
  Indication 1:Obesity; Indication 2:Insulin Resistance